HPK may have utility for distinguishing distinctly different transport mechanisms in endothelia versus tumour cells entailing non-degradative CAV1-dependent transendothelial transport followed by tumour entry through an endosomolytic pathway. The gene discussed is CAV1; the disease is neoplasm.